FIELD: medicine.
SUBSTANCE: in order to stimulate anti-tumour activity of cytotoxic effectors of immune system into organism of person with tumour introduced are recombinant proteins, containing mini-antibody to tumour-specific antigens and molecule "БТШ70".
EFFECT: invention makes it possible to activate anti-tumour immune response, connected with NK-cell activation, due to targeted delivery to the surface of tumor cells of "БТШ70" molecules.
3 ex, 4 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| PROTEIN-PEPTIDE ANTITUMOR COMPOSITION, CELL PREPARATION ACTIVATED THEREWITH AND METHOD FOR TUMOR PROPHYLAXIS OR TREATMENT | 2004 |
|
RU2283129C1 |
| GENETIC STRUCTURE RBCT70 FOR EXPRESSION OF THE MAIN HUMAN STRESS PROTEIN IN MILK OF TRANSGENIC ANIMALS | 2015 |
|
RU2644663C2 |
| VACCINE COMPOSITION FOR PROPHYLAXIS AND TREATMENT OF TUMOR DISEASES, RECOMBINANT PLASMID DNA PROVIDING HYBRID PROTEIN SYNTHESIS AND METHOD FOR PRODUCTION THEREOF | 2006 |
|
RU2316342C1 |
| VACCINE COMPOSITIONS, METHODS FOR APPLICATION THEREOF IN MELANOMA PREVENTION AND TREATMENT, AND GENETIC CONSTRUCTIONS FOR OBTAINING ACTIVE SUBSTANCES OF COMPOSITION | 2006 |
|
RU2333767C2 |
| BIOMEDICAL CELL PRODUCT FOR TREATMENT OF MALIGNANT NEOPLASMS | 2023 |
|
RU2813531C1 |
| METHOD OF THERAPY OF MALIGNANT DISEASES | 2013 |
|
RU2597414C2 |
| METHOD FOR PRODUCTION OF IN VITRO POPULATIONS OF ACTIVATED ANTIGENSPECIFIC ANTITUMOR-TUMOR CYTOTOXIC T-LYMPHOCYTES SPECIFIC TO TUMOR-ASSOCIATED ANTIGEN EPITOPES | 2016 |
|
RU2619186C1 |
| CHIMERIC ANTIGEN RECEPTORS WITH MUTATED CD28 COSTIMULATION DOMAINS | 2018 |
|
RU2800922C2 |
| MONOCLONAL ANTIBODY TO HEAT SHOCK PROTEIN 70 | 2019 |
|
RU2722398C1 |
| PSCA-CAR-YT CELL LINE HAVING SURFACE EXPRESSION OF CHIMERIC ANTIGEN RECEPTORS AND EXHIBITING CYTOTOXIC ACTIVITY ON PSCA-POSITIVE HUMAN CANCER CELLS | 2018 |
|
RU2712901C1 |
